Literature DB >> 21329469

What is the role of assisted reproduction technology in the management of age-related infertility?

Gerasimos Marinakis1, Dimitrios Nikolaou.   

Abstract

Although in the UK the upper age limit for National Health Service (NHS) provision of in vitro fertilisation (IVF) is 39 years of age there has been an increase in number of women having fertility treatment in their 40s. However, the success rates of IVF and intra-uterine insemination (IUI) in this group remain low. Human Fertilisation and Embryology Authority (HFEA) data from 2006 showed that the live-birth rate from IVF in the UK was 11% in the age group 40-42, 4.6% in the age group 43-44 and less than 4% in women over 44. We performed a literature search for studies using terms and combinations of terms in online databases and published meta-analyses reporting the outcome of interventions in older women. This review showed that assisted reproduction technologies (ARTs) continue to have low live-birth rates in women over 40. Trials showed that assisted hatching may increase the chance of pregnancy in women with poor history. Blastocyst transfer is associated with better outcome, whereas application of pre-implantation genetic screening (PGS) in older women has not increased the success rates. It appears that, with the exception of egg-donation, ART has no answer yet to age-related decline of female fertility.

Entities:  

Mesh:

Year:  2011        PMID: 21329469     DOI: 10.3109/14647273.2010.549162

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  7 in total

1.  Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans.

Authors:  Shiny Titus; Fang Li; Robert Stobezki; Komala Akula; Evrim Unsal; Kyungah Jeong; Maura Dickler; Mark Robson; Fred Moy; Sumanta Goswami; Kutluk Oktay
Journal:  Sci Transl Med       Date:  2013-02-13       Impact factor: 17.956

2.  Assisted reproduction counseling in women aged 40 and above: a cohort study.

Authors:  Michaël De Brucker; Herman Tournaye; Patrick Haentjens; Greta Verheyen; John Collins; Michel Camus
Journal:  J Assist Reprod Genet       Date:  2013-08-28       Impact factor: 3.412

3.  IVF results in patients with very low serum AMH are significantly affected by chronological age.

Authors:  Alberto Revelli; Valentina Biasoni; Gianluca Gennarelli; Stefano Canosa; Paola Dalmasso; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2016-02-18       Impact factor: 3.412

4.  Matrix metalloproteinases 2 and 9 and e-cadherin expression in the endometrium during the implantation window of infertile women before in vitro fertilization treatment.

Authors:  Vamberto O A Maia-Filho; Andre M Rocha; Fernando P Ferreira; Tatiana C S Bonetti; Paulo Serafini; Eduardo L A Motta
Journal:  Reprod Sci       Date:  2014-04-03       Impact factor: 3.060

5.  Vasodilators for women undergoing fertility treatment.

Authors:  Rosa B Gutarra-Vilchez; Xavier Bonfill Cosp; Demián Glujovsky; Andres Viteri-García; Fernando M Runzer-Colmenares; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12

6.  Differential expression of pluripotent and germ cell markers in ovarian surface epithelium according to age in female mice.

Authors:  Bo Sun Joo; In Kook Jung; Min Jung Park; Jong Kil Joo; Ki Hyung Kim; Kyu-Sup Lee
Journal:  Reprod Biol Endocrinol       Date:  2014-11-24       Impact factor: 5.211

7.  The "graying" of infertility services: an impending revolution nobody is ready for.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2014-07-09       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.